These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32134146)
1. Impact of Enteral Feeding on Vasoactive Support in Septic Shock: A Retrospective Observational Study. Ewy M; Aqeel M; Kozeniecki M; Patel K; Banerjee A; Heyland DK; Patel JJ Nutr Clin Pract; 2020 Jun; 35(3):540-547. PubMed ID: 32134146 [TBL] [Abstract][Full Text] [Related]
2. Tolerability of Enteral Nutrition in Mechanically Ventilated Patients With Septic Shock Who Require Vasopressors. Merchan C; Altshuler D; Aberle C; Papadopoulos J; Schwartz D J Intensive Care Med; 2017 Oct; 32(9):540-546. PubMed ID: 27377392 [TBL] [Abstract][Full Text] [Related]
3. Early Trophic Enteral Nutrition Is Associated With Improved Outcomes in Mechanically Ventilated Patients With Septic Shock: A Retrospective Review. Patel JJ; Kozeniecki M; Biesboer A; Peppard W; Ray AS; Thomas S; Jacobs ER; Nanchal R; Kumar G J Intensive Care Med; 2016 Aug; 31(7):471-7. PubMed ID: 25315218 [TBL] [Abstract][Full Text] [Related]
5. Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy. Mancl EE; Muzevich KM JPEN J Parenter Enteral Nutr; 2013 Sep; 37(5):641-51. PubMed ID: 23270986 [TBL] [Abstract][Full Text] [Related]
6. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions. Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock. Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I; Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559 [TBL] [Abstract][Full Text] [Related]
8. Correlation analysis of norepinephrine dose on enteral nutrition tolerance and prognosis in patients with septic shock. Qi F; Huang G; Li H; Zhao X; Liu J BMC Infect Dis; 2023 Jun; 23(1):386. PubMed ID: 37291494 [TBL] [Abstract][Full Text] [Related]
9. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock. Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496 [TBL] [Abstract][Full Text] [Related]
10. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock. DeMott JM; Patel G; Lat I Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416 [TBL] [Abstract][Full Text] [Related]
11. Phase 3 Pilot Randomized Controlled Trial Comparing Early Trophic Enteral Nutrition With "No Enteral Nutrition" in Mechanically Ventilated Patients With Septic Shock. Patel JJ; Kozeniecki M; Peppard WJ; Peppard SR; Zellner-Jones S; Graf J; Szabo A; Heyland DK JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):866-873. PubMed ID: 31535394 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis. Durst MM; Eitzen EA; Benken ST Ann Pharmacother; 2021 Aug; 55(8):970-979. PubMed ID: 33327736 [TBL] [Abstract][Full Text] [Related]
14. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICEĀ III] Trial. Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R; Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054 [TBL] [Abstract][Full Text] [Related]
15. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093 [TBL] [Abstract][Full Text] [Related]
16. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). Jeon K; Song JU; Chung CR; Yang JH; Suh GY Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057 [TBL] [Abstract][Full Text] [Related]
17. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock. Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732 [TBL] [Abstract][Full Text] [Related]
18. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock. Vadiei N; Daley MJ; Murthy MS; Shuman CS Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982 [TBL] [Abstract][Full Text] [Related]
19. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock. Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850 [TBL] [Abstract][Full Text] [Related]
20. Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient. Adams C; Tucker C; Allen B; McRae A; Balazh J; Horst S; Johnson D; Ferreira J J Crit Care; 2017 Feb; 37():219-223. PubMed ID: 27969574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]